Survival of patients with advanced metastatic melanoma: The impact of novel therapies-Reference-Cited by-同舟云学术

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

Published:2016-01 Issue: Volume:53 Page:125-134
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ugurel Selma,Röhmel Joachim,Ascierto Paolo A.,Flaherty Keith T.,Grob Jean Jacques,Hauschild Axel,Larkin James,Long Georgina V.,Lorigan Paul,McArthur Grant A.,Ribas Antoni,Robert Caroline,Schadendorf Dirk,Garbe Claus

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials;Eigentler;Lancet Oncol,2003

2. Cutaneous melanoma;Eggermont;Lancet,2014

3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

4. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

5. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N Engl J Med,2012

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutical Usefulness of PD-1/PD-L1 Inhibitors in Aggressive or Metastatic Pituitary Tumours;Cancers;2024-08-30

2. Long-Term Survival in Patients With Advanced Melanoma;JAMA Network Open;2024-08-14

3. Novel Macrophage Subtype Genes for Predicting Prognosis and Immunotherapy Response in Melanoma Based on Single-Cell and Bulk RNA Sequencing Analysis;2024-06-10

4. Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma;Cellular & Molecular Biology Letters;2024-04-10

5. Immune subtyping of melanoma whole slide images using multiple instance learning;Medical Image Analysis;2024-04